iridium radioisotopes has been researched along with Hemorrhage in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Böning, G; Büttner, L; Denecke, T; Gebauer, B; Jonczyk, M; Lüdemann, WM; Schnapauff, D; Wieners, G; Wust, P | 1 |
Akasaka, T; Ehara, S; Harada, S; Nakamura, R; Obara, T; Shozushima, M; Yoshida, A | 1 |
Komune, S; Matsumura, T; Nakamuta, M; Okura, K; Sakiyama, Y; Uehara, S; Yamamoto, T; Yasumatsu, R | 1 |
Kamada, T; Nojima, T; Okushiba, SI; Saitou, H; Takamura, A | 1 |
Bianco, J; Boulware, RJ; Greene, FL | 1 |
Holmes, DR | 1 |
1 review(s) available for iridium radioisotopes and Hemorrhage
Article | Year |
---|---|
Metastatic hepatocellular carcinoma of the external auditory canal.
Topics: Angiography; Brachytherapy; Carcinoma, Hepatocellular; Ear Canal; Ear Neoplasms; Earache; Fatal Outcome; Hearing Loss; Hemorrhage; Hepatitis B; Humans; Iridium Radioisotopes; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Otologic Surgical Procedures; Radiotherapy, Adjuvant; Treatment Outcome | 2007 |
5 other study(ies) available for iridium radioisotopes and Hemorrhage
Article | Year |
---|---|
Complications of Computed Tomography-Guided High-Dose-Rate Brachytherapy (CT-HDRBT) and Risk Factors: Results from More than 10 Years of Experience.
Topics: Aged; Brachytherapy; Dose-Response Relationship, Radiation; Female; Hemorrhage; Humans; Infections; Iridium Radioisotopes; Male; Middle Aged; Neoplasms; Pain; Radiography, Interventional; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Iridium-192 brachytherapy for hemorrhagic angiosarcoma of the scalp: a case report.
Topics: Brachytherapy; Dose Fractionation, Radiation; Female; Head and Neck Neoplasms; Hemangiosarcoma; Hemorrhage; Humans; Iridium Radioisotopes; Middle Aged; Radiotherapy Dosage; Scalp; Skin Neoplasms | 2003 |
The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts; Bile Ducts, Extrahepatic; Brachytherapy; Cause of Death; Combined Modality Therapy; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Iridium Radioisotopes; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis | 1996 |
Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
Topics: Adenocarcinoma; Brachytherapy; Carcinoma, Squamous Cell; Catheterization; Deglutition; Deglutition Disorders; Enteral Nutrition; Esophageal Diseases; Esophageal Fistula; Esophageal Neoplasms; Esophagogastric Junction; Esophagoscopy; Esophagus; Female; Follow-Up Studies; Gastroscopy; Gastrostomy; Hemorrhage; Humans; Iridium Radioisotopes; Male; Radiotherapy Dosage; Remission Induction; Survival Rate | 1995 |
Preventing coronary restenosis and complications.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Disease; Hemorrhage; Heparin; Humans; Immunoglobulin Fab Fragments; Iridium Radioisotopes; Myocardial Ischemia; Platelet Aggregation Inhibitors; Recurrence; Stents | 1997 |